Monday, July 15, 2024

Pharmaceutical Price Reduction Focus of New Prime Therapeutics and Magellan Rx Partnership

Similar articles

Pharmaceutical price reduction is the focus of a new partnership announced by Prime Therapeutics and Magellan Rx Management, which will launch a pharmaceutical platform aimed at plan sponsors, leveraging real-time pricing and an expanded pharmacy network to drive down costs. This platform, named Pharmacy Match, will be offered at no additional cost to Prime/MRx program members, providing an innovative approach to managing specialty pharmaceutical prices.

Nathan Downhour, Prime/MRx’s Senior Vice President of Pharmacy and Care Solutions, emphasized the platform’s significance in a press release. “Providing access to rapidly expanding specialty treatments while controlling cost is one of the biggest challenges facing healthcare today. Pharmacy Match is one example of how we are working to expand access to affordable medications while helping members navigate their specialty journey,” he said.

Downhour further elaborated on the platform’s potential, stating, “Prime/MRx’s priority is to improve the specialty pharmacy ecosystem. We envision an intelligently designed, technology-enabled specialty care model that improves the experience for members, from prescription intake to fulfillment, while eliminating complexities, driving savings, and reducing waste. Pharmacy Match is our first step toward this vision.”

New Platform by Prime/MRx Aims to Consolidate Specialty Pharmaceutical Markets and Reduce Costs

The core objective of the platform is to consolidate options for specialty pharmaceutical offerings. Specialty drugs often exist in a fragmented market, which limits plan providers’ options and drives up prices. By integrating these markets, Prime/MRx aims to provide more choices and reduce costs for plan providers.

Joe Cardosi, founder, and CEO of Free Market Health, highlighted the benefits of the platform, stating, “Our technology platform is a proven flexible solution that delivers plan sponsors unprecedented control over their specialty drug management programs, enabling them to efficiently balance the cost of care with the value that care provides in their unique markets. We’re excited to partner with Prime as we share a common goal of streamlining the fragmented drug delivery system so patients can seamlessly start and continue their specialty pharmaceutical treatments to achieve the best possible outcomes.”

The platform’s innovative approach combines real-time pricing with an expanded pharmacy network, aiming to offer plan sponsors better control over their specialty pharmaceutical management programs. This control is expected to help balance the cost of care with the value provided, addressing one of the most significant challenges in healthcare today—controlling the cost of rapidly expanding specialty treatments while ensuring patient access.


Pharmaceutical Leadership Strengthened as Prime Therapeutics Appoints Mike Edwards Amid New Partnership

In addition to this partnership, Prime Therapeutics recently announced the appointment of Mike Edwards as the President of Markets. Edwards will oversee the company’s growth and client engagement services, bringing extensive expertise and a proven track record to the role. Prime Therapeutics’ CEO, Mostafa Kamal, expressed confidence in Edwards’ leadership.

“Mike is an accomplished leader with deep expertise in our business and a proven track record. I am thrilled he is joining our leadership team as we sharpen our focus on delivering differentiated solutions and services to our clients. Under Mike’s leadership, we will bring together our enterprise-wide sales, client engagement, and Medicare and Medicaid teams with a laser focus on being consultative partners with our clients to deeply understand their strategies and needs.”

You can follow our news on our Telegram and LinkedIn accounts.

The Pharmacy Match platform represents a significant step toward transforming the specialty pharmacy ecosystem. By integrating real-time pricing and expanding the pharmacy network, Prime Therapeutics, and Magellan Rx Management aim to reduce the cost and complexity of specialty pharmaceutical management. This collaboration seeks to enhance the overall experience for members, from prescription intake to fulfillment, and ensure that patients receive the best possible outcomes from their treatments.

In conclusion, the partnership between Prime Therapeutics and Magellan Rx Management marks a promising development in the effort to control specialty pharmaceutical costs and improve patient care. Through innovative solutions like Pharmacy Match, the companies are addressing the challenges of the fragmented specialty drug market, providing plan sponsors with more options and better control over pharmaceutical management programs. This initiative not only aims to drive savings but also to enhance the quality of care for patients requiring specialty treatments. As the healthcare landscape continues to evolve, such collaborations are essential in meeting the growing demand for affordable and effective medical solutions.


Resource: PR Newswire, June 19, 2024

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article